About Matthew Fraser
Matthew Fraser is a co-founder, chief scientific officer and director at Paxos Medical.
Experience
This experience comes from Matthew Fraser's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Fraser in the role, so the role may have started earlier or lasted longer.
DC
Department of Urology, Duke University Medical Center Current
Adjunct Associate Professor
2026 – Present
Paxos Medical Inc. Current
Co-Founder, Chief Scientific Officer and director
Chief Scientific Officer, Co-Founder, BOD (2023 – Present)
2023 – Present · Maple Plain, MN
Develops an implant to help people with underactive bladder urinate on demand.
NL
NeuroUroGastro Preclinical Research Consulting, LLC Current
President
2009 – Present
DC
Durham Veterans Affairs Medical Center
Research Physiologist
2009 – 2024
FI
Fernel Therapeutics, Inc.
President, Chief Scientific Officer
2021 – 2023
TR
The Society for Pelvic Research
President
2015 – 2019
UI
Urogenix, Inc
Director of In Vivo Pharmacology
2006 – 2009
DP
Dynogen Pharmaceuticals
Director of In Vivo Pharmacology
2002 – 2006
Key Colleagues at Startups
The people Matthew Fraser works with at each company, as listed on that company's latest Form D.
Paxos Medical Inc. · Form D, May 14, 2026
JE
Jeffrey Erb
Co-Founder, Chief Executive Officer and director